CHICAGO--(BUSINESS WIRE)-- Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company’s unique ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback